Open Access
Development of molecular tools for diagnosis of Alzheimer’s disease that are based on detection of amyloidogenic proteins
Sergei A Fedotov
1, 2
,
Maria S. Rubel
3
,
Natalia M Zalutskaya
4
,
Anastasia E Zobnina
1, 5
,
Oksana A Malikova
1, 5
,
Nikolay G Neznanov
4
,
Yury O Chernoff
1, 6
,
Aleksandr A. Rubel
1, 5, 7
4
Тип публикации: Journal Article
Дата публикации: 2021-01-01
scimago Q3
wos Q4
БС3
SJR: 0.555
CiteScore: 3.6
Impact factor: 1.6
ISSN: 19336896, 1933690X
PubMed ID:
33910450
Biochemistry
Cell Biology
Infectious Diseases
Cellular and Molecular Neuroscience
Краткое описание
ABSTRACT Alzheimer’s disease (AD) is the most common form of dementia that usually occurs among older people. AD results from neuronal degeneration that leads to the cognitive impairment and death. AD is incurable, typically develops over the course of many years and is accompanied by a loss of functional autonomy, making a patient completely dependent on family members and/or healthcare workers. Critical features of AD are pathological polymerization of Aβ peptide and microtubule-associated protein tau, accompanied by alterations of their conformations and resulting in accumulation of cross-β fibrils (amyloids) in human brains. AD apparently progresses asymptomatically for years or even decades before the appearance of symptoms. Therefore, development of the early AD diagnosis at a pre-symptomatic stage is essential for potential therapies. This review is focused on current and potential molecular tools (including non-invasive methods) that are based on detection of amyloidogenic proteins and can be applicable to early diagnosis of AD. Abbreviations: Aβ – amyloid-β peptide; AβO – amyloid-β oligomers; AD – Alzheimer’s disease; ADRDA – Alzheimer’s Disease and Related Disorders Association; APH1 - anterior pharynx defective 1; APP – amyloid precursor protein; BACE1 – β-site APP-cleaving enzyme 1; BBB – brain blood barrier; CJD - Creutzfeldt-Jakob disease; CRM – certified reference material; CSF – cerebrospinal fluid; ELISA – enzyme-linked immunosorbent assay; FGD – 18F-fluorodesoxyglucose (2-deoxy-2-[18F]fluoro-D-glucose); IP-MS – immunoprecipitation-mass spectrometry assay; MCI – mild cognitive impairment; MDS – multimer detection system; MRI – magnetic resonance imaging; NIA-AA – National Institute on Ageing and Alzheimer’s Association; NINCDS – National Institute of Neurological and Communicative Disorders and Stroke; PEN2 – presenilin enhancer 2; PET – positron emission tomography; PiB – Pittsburgh Compound B; PiB-SUVR - PIB standardized uptake value ratio; PMCA – Protein Misfolding Cycling Amplification; PrP – Prion Protein; P-tau – hyperphosphorylated tau protein; RMP – reference measurement procedure; RT-QuIC - real-time quaking-induced conversion; SiMoA – single-molecule array; ThT – thioflavin T; TSEs – Transmissible Spongiform Encephslopathies; T-tau – total tau protein
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
1
2
3
|
|
|
Frontiers in Aging Neuroscience
3 публикации, 15%
|
|
|
International Journal of Molecular Sciences
2 публикации, 10%
|
|
|
Clinical and Translational Oncology
1 публикация, 5%
|
|
|
Aging clinical and experimental research
1 публикация, 5%
|
|
|
ACS applied materials & interfaces
1 публикация, 5%
|
|
|
Brain Research Bulletin
1 публикация, 5%
|
|
|
Cells
1 публикация, 5%
|
|
|
BMC Neurology
1 публикация, 5%
|
|
|
Life
1 публикация, 5%
|
|
|
European Journal of Medicinal Chemistry
1 публикация, 5%
|
|
|
ACS Chemical Neuroscience
1 публикация, 5%
|
|
|
Physics of Particles and Nuclei
1 публикация, 5%
|
|
|
Microchemical Journal
1 публикация, 5%
|
|
|
Lecture Notes in Computer Science
1 публикация, 5%
|
|
|
ChemBioChem
1 публикация, 5%
|
|
|
Developmental Neurobiology
1 публикация, 5%
|
|
|
Journal of Neurochemistry
1 публикация, 5%
|
|
|
1
2
3
|
Издатели
|
1
2
3
4
|
|
|
MDPI
4 публикации, 20%
|
|
|
Springer Nature
4 публикации, 20%
|
|
|
Frontiers Media S.A.
3 публикации, 15%
|
|
|
Elsevier
3 публикации, 15%
|
|
|
Wiley
3 публикации, 15%
|
|
|
American Chemical Society (ACS)
2 публикации, 10%
|
|
|
Pleiades Publishing
1 публикация, 5%
|
|
|
1
2
3
4
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
20
Всего цитирований:
20
Цитирований c 2024:
9
(45%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Kulichikhin K. Y. et al. Development of molecular tools for diagnosis of Alzheimer’s disease that are based on detection of amyloidogenic proteins // Prion. 2021. Vol. 15. No. 1. pp. 56-69.
ГОСТ со всеми авторами (до 50)
Скопировать
Kulichikhin K. Y., Fedotov S. A., Rubel M. S., Zalutskaya N. M., Zobnina A. E., Malikova O. A., Neznanov N. G., Chernoff Y. O., Rubel A. A. Development of molecular tools for diagnosis of Alzheimer’s disease that are based on detection of amyloidogenic proteins // Prion. 2021. Vol. 15. No. 1. pp. 56-69.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1080/19336896.2021.1917289
UR - https://doi.org/10.1080/19336896.2021.1917289
TI - Development of molecular tools for diagnosis of Alzheimer’s disease that are based on detection of amyloidogenic proteins
T2 - Prion
AU - Kulichikhin, Konstantin Y
AU - Fedotov, Sergei A
AU - Rubel, Maria S.
AU - Zalutskaya, Natalia M
AU - Zobnina, Anastasia E
AU - Malikova, Oksana A
AU - Neznanov, Nikolay G
AU - Chernoff, Yury O
AU - Rubel, Aleksandr A.
PY - 2021
DA - 2021/01/01
PB - Taylor & Francis
SP - 56-69
IS - 1
VL - 15
PMID - 33910450
SN - 1933-6896
SN - 1933-690X
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2021_Kulichikhin,
author = {Konstantin Y Kulichikhin and Sergei A Fedotov and Maria S. Rubel and Natalia M Zalutskaya and Anastasia E Zobnina and Oksana A Malikova and Nikolay G Neznanov and Yury O Chernoff and Aleksandr A. Rubel},
title = {Development of molecular tools for diagnosis of Alzheimer’s disease that are based on detection of amyloidogenic proteins},
journal = {Prion},
year = {2021},
volume = {15},
publisher = {Taylor & Francis},
month = {jan},
url = {https://doi.org/10.1080/19336896.2021.1917289},
number = {1},
pages = {56--69},
doi = {10.1080/19336896.2021.1917289}
}
Цитировать
MLA
Скопировать
Kulichikhin, Konstantin Y., et al. “Development of molecular tools for diagnosis of Alzheimer’s disease that are based on detection of amyloidogenic proteins.” Prion, vol. 15, no. 1, Jan. 2021, pp. 56-69. https://doi.org/10.1080/19336896.2021.1917289.